年単位の研究成果
Fingerprint Kenro Hirataが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。
- 9 同様のプロファイル
Helicobacter pylori
Medicine & Life Sciences
Metronidazole
Medicine & Life Sciences
MicroRNAs
Medicine & Life Sciences
Stomach Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Stomach
Medicine & Life Sciences
Pancreatic Neoplasms
Medicine & Life Sciences
Rifabutin
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 2006 2019
- 799 引用
- 16 h指数
- 34 Article
Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm
Kashiwagi, K., Minami, K., Seino, T., Hirata, K., Iwasaki, E., Inoue, N., Iwao, Y. & Kanai, T., 2019 1 1, (Accepted/In press) ： : Journal of Digestive Diseases.研究成果: Article
Cysts
Fats
Odds Ratio
Confidence Intervals
Pancreas
3
引用
(Scopus)
Unmet needs of cancer patients with chemotherapy-related hand-foot syndrome and targeted therapy-related hand-foot skin reaction: A qualitative study
Komatsu, H., Yagasaki, K., Hirata, K. & Hamamoto, Y., 2019 2 1, ： : European Journal of Oncology Nursing. 38, p. 65-69 5 p.研究成果: Article
Hand-Foot Syndrome
Foot
Hand
Drug Therapy
Skin
4
引用
(Scopus)
Inhibiting xCT improves 5-fluorouracil resistance of gastric cancer induced by CD44 variant 9 expression
Miyoshi, S., Tsugawa, H., Matsuzaki, J., Hirata, K., Mori, H., Saya, H., Kanai, T. & Suzuki, H., 2018 11 1, ： : Anticancer Research. 38, 11, p. 6163-6170 8 p.研究成果: Article
Fluorouracil
Stomach Neoplasms
Neoplastic Stem Cells
Antiporters
Drug Therapy
1
引用
(Scopus)
Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis
Kasuga, A., Hamamoto, Y., Takeuchi, A., Okano, N., Togasaki, K., Aoki, Y., Suzuki, T., Kawasaki, K., Hirata, K., Sukawa, Y., Kanai, T. & Takaishi, H., 2018 3 23, (Accepted/In press) ： : Investigational New Drugs. p. 1-10 10 p.研究成果: Article
gemcitabine
Pancreatic Neoplasms
Meta-Analysis
Drug Therapy
Survival
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report
Kawasaki, K., Hamamoto, Y., Suzuki, T., Hirata, K., Sukawa, Y., Kasuga, A., Hayashi, Y., Takaishi, H., Kameyama, K. & Kanai, T., 2017, ： : Oncology Letters. 14, 3, p. 3697-3700 4 p.研究成果: Article
Rectal Neoplasms
Colorectal Neoplasms
Therapeutics
Neuroendocrine Carcinoma
Etoposide